Plain-English translation of NCT04949282 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
SEPTRALU is a Spanish research project collecting medical information from patients who have been treated with Lutathera, a radioactive medication designed to target certain types of cancer. Researchers want to learn more about how this treatment works in real patients and how it affects their outcomes over time. By gathering data from thousands of patients, they hope to better understand who benefits most from this therapy.
Many patients with advanced neuroendocrine tumors and related cancers have limited treatment options. This study exists to collect real-world evidence about how this medication performs in everyday clinical practice, which can help doctors make better treatment decisions for future patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your medical records with your permission to collect information about your treatment and how you've responded to it. You won't need to attend study visits or receive new treatment — the researchers are simply gathering data from your existing medical care. This is a way to contribute to research that helps doctors understand this treatment better, without extra burden on your part.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Spain